There are around 12,100 people diagnosed with a tumour in the brain or central nervous system (CNS) each year in the UK. Brain and spinal cord tumours can affect children and adults and common symptoms include headaches, feeling or being sick and seizures (fits).
This Childhood Cancer Awareness Month, we caught up with families who have been affected by children’s and young people’s cancers to find out how COVID-19 has impacted them and their loved ones.
Find out how the chemistry inside plants can lead to life-changing drugs and how a cannabis-derived drug is part of a new trial to help people with a type of aggressive brain cancer.
Cancer Research UK scientists are developing tests that can detect the presence of glioma, a type of brain tumour, in patient urine or blood plasma.
We spoke to Dr Kate Cwynarski, who led the Stand Up To Cancer-funded MARIETTA trial, a clinical trial which details a “potentially transforming” treatment for some patients with secondary CNS lymphoma.
Cancer Research UK scientists have developed a new way to analyse blood for evidence of cancer that could be up to ten times more sensitive than previous methods.
‘The word ‘legacy’ is often overused, but not about the late Baroness Tessa Jowell’. Michelle Mitchell reflects on Cancer Research UK’s new brain tumour funding.
Meet our three new international teams of scientists that have been awarded £18 million to revolutionise brain tumour research.
Three research teams have been awarded a combined total of £18 million to break new ground in the way we understand brain tumours and how they develop.
Potential new drug targets for an aggressive type of brain tumour have been uncovered in the lab, thanks to a ‘reverse engineering’ approach using DNA editing.